Skip to main content
UniHealth

Doctor search

Sinda M Mein, MD

Gastroenterology · Menlo Park

NPI 1376657734

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
9
1 carrier
Office
1

Offices

1 location · University Healthcare Alliance · 334 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

9 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mein’s office at (650) 498-6500 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026

California Medical Board record

Licence A69657 · Current

Licensed to practise in California · since 1999 · expires 2026-11-30 · University of Southern California Keck School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Surgery centers they own

  • Waverley Surgery Center, LPAmbulatory Surgery Center · Palo Alto, CA4.13% owner since 2018 · accredited by AAAHC
    Accreditation Renewed4 inspections, 3 with deficiencies · last 2024-04-25

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$78,565

Medicare paid this office $78,565 for 288 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)153$24,655$111
Removal of polyps or growths of large bowel using an endoscope with mechanical snare82$19,312$236
Biopsy of large bowel using a flexible endoscope119$11,238$94
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope80$7,539$91
New patient visit (45+ min)52$7,423$143
See all 7 services
Every Original Medicare service billed
Return visit (30+ min)153$24,655$111
Removal of polyps or growths of large bowel using an endoscope with mechanical snare82$19,312$236
Biopsy of large bowel using a flexible endoscope119$11,238$94
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope80$7,539$91
New patient visit (45+ min)52$7,423$143
Long return visit (40+ min)22$4,097$164
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's68$1,094$14

Procedures Medicare counted

Procedure volume Medicare published
Colonoscopy39More than 59% of doctors who do this
Upper gastrointestinal (GI) endoscopy for acid reflux38More than 59% of doctors who do this

Who their Medicare patients are

288 Original Medicare patients in 2024. Average age 76 · Women 75% · Also on Medicaid 4% · Health risk score 0.95. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.

Conditions among them: High blood pressure 58% · Coronary heart disease 24% · Diabetes 17% · Cancer 17% · Depression 17% · Chronic kidney disease 13% · Atrial fibrillation 13% · COPD 8% · Heart failure 6% · Stroke 6%.

The office billed $811,556, Medicare allowed $101,631 and paid $78,565; for 697 services of 25 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024288697760.95$811,556$78,565
2023264552750.96$693,962$67,542
2022273539750.90$682,530$63,686
2021265565740.93$655,826$71,566
2020200383751.10$399,222$43,132
2019219479751.06$511,756$55,618
2018253765740.92$536,521$61,268
20173481,041751.00$704,207$78,806
2016347668730.90$649,344$79,741
2015309641730.85$641,492$87,789
2014279536730.97$507,788$65,752
2013212453721.16$381,493$51,997

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 7 services

Original Medicare services billed in 2023
Return visit (30+ min)127$19,684$110
Removal of polyps or growths of large bowel using an endoscope with mechanical snare74$16,341$221
Biopsy of large bowel using a flexible endoscope103$7,865$76
New patient visit (45+ min)45$6,081$135
Long return visit (40+ min)31$5,259$164
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope58$4,897$82
Diagnostic exam of anus with magnification and chemical agent enhancement using an endoscope15$2,094$131

2022: 7 services

Original Medicare services billed in 2022
Return visit (30+ min)125$16,982$105
Removal of polyps or growths of large bowel using an endoscope with mechanical snare78$16,448$211
Biopsy of large bowel using a flexible endoscope119$8,689$73
New patient visit (45+ min)50$6,823$136
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope57$5,028$88
Long return visit (40+ min)21$3,623$151
Diagnostic exam of anus with magnification and chemical agent enhancement using an endoscope12$1,617$124

2021: 8 services

Original Medicare services billed in 2021
Return visit (30+ min)138$24,079$122
Removal of polyps or growths of large bowel using an endoscope with mechanical snare62$13,548$219
Biopsy of large bowel using a flexible endoscope112$11,182$100
New patient visit (45+ min)52$7,346$141
Long return visit (40+ min)24$4,896$175
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope56$4,469$77
Diagnostic exam of anus with magnification and chemical agent enhancement using an endoscope12$1,670$139
Short return visit (20+ min)12$752$63

2020: 8 services

Original Medicare services billed in 2020
Return visit (30+ min)98$12,438$96
Removal of polyps or growths of large bowel using an endoscope with mechanical snare29$6,494$224
Biopsy of large bowel using a flexible endoscope56$6,352$113
Long return visit (40+ min)26$4,274$138
New patient visit (45+ min)30$4,181$139
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope40$4,071$99
Telephone medical discussion with physician, 21-30 minutes12$1,360$105
Short return visit (20+ min)18$1,235$69

2019: 8 services

Original Medicare services billed in 2019
Return visit (30+ min)116$16,531$101
Biopsy of large bowel using a flexible endoscope80$9,557$118
New patient visit (45+ min)62$9,035$146
Removal of polyps or growths of large bowel using an endoscope with mechanical snare33$7,612$224
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope49$4,553$91
Long return visit (40+ min)16$2,883$137
Short return visit (20+ min)27$1,985$71
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito14$68$5

2018: 9 services

Original Medicare services billed in 2018
Return visit (30+ min)108$13,629$93
Biopsy of large bowel using a flexible endoscope106$12,136$114
Removal of polyps or growths of large bowel using an endoscope with mechanical snare51$11,557$227
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope65$6,046$90
New patient visit (45+ min)33$4,925$149
Long return visit (40+ min)19$2,355$124
Short return visit (20+ min)22$1,338$56
Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes83$1,296$11
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito144$700$5

2017: 12 services

Original Medicare services billed in 2017
Biopsy of large bowel using a flexible endoscope146$17,118$117
Removal of polyps or growths of large bowel using an endoscope with mechanical snare67$15,909$234
Return visit (30+ min)116$14,132$95
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope73$7,095$89
New patient visit (45+ min)42$6,187$147
Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes140$2,099$11
Long return visit (40+ min)14$1,902$119
Short return visit (20+ min)31$1,804$58
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes17$1,490$88
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito172$806$4
Injection beneath lining of large bowel using a flexible endoscope15$399$27
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes28$295$11

2016: 9 services

Original Medicare services billed in 2016
Biopsy of large bowel using a flexible endoscope147$17,046$116
Removal of polyps or growths of large bowel using an endoscope with mechanical snare73$16,870$231
Return visit (30+ min)105$14,090$95
New patient visit (45+ min)52$7,048$136
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope61$5,141$83
Short return visit (20+ min)46$3,585$62
Long return visit (40+ min)15$2,016$126
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes13$1,160$89
Injection beneath lining of large bowel using a flexible endoscope13$377$29

2015: 8 services

Original Medicare services billed in 2015
Biopsy of large bowel using a flexible endoscope151$23,018$150
Removal of polyps or growths of large bowel using an endoscope with mechanical snare76$22,042$286
Return visit (30+ min)96$12,803$101
New patient visit (45+ min)53$7,720$146
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope62$5,350$85
Short return visit (20+ min)48$3,735$68
Long return visit (40+ min)14$2,284$134
Injection beneath lining of large bowel using a flexible endoscope17$459$27

2014: 9 services

Original Medicare services billed in 2014
Biopsy of large bowel using a flexible endoscope118$18,760$158
Removal of polyps or growths of large bowel using an endoscope with mechanical snare51$13,757$265
Short return visit (20+ min)96$7,786$62
New patient visit (45+ min)39$5,675$146
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope60$5,472$88
Return visit (30+ min)25$2,557$88
New patient visit (30+ min)13$991$76
Short return visit11$486$37
Injection beneath lining of large bowel using a flexible endoscope11$315$26

2013: 10 services

Original Medicare services billed in 2013
Biopsy of large bowel using a flexible endoscope65$10,043$152
Removal of polyps or growths of large bowel using an endoscope with mechanical snare36$9,338$252
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope56$7,483$125
Short return visit (20+ min)81$7,429$66
New patient visit (45+ min)27$3,722$138
Biopsy of lower large bowel using a flexible endoscope11$1,918$160
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes15$1,307$87
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes16$1,076$34
New patient visit (30+ min)11$909$83
Short return visit17$630$37

Drugs they prescribed that Part D paid

$426,164

Pharmacies billed $426,164 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 760) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.

575 generic and 185 brand-name prescriptions · $426,164 in drug cost · 21 antibiotic prescriptions to 15 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Linzess56$53,956$963
Creon11$28,533$2,594
Motegrity27$27,299$1,011
Dexlansoprazole Dr36$11,773$327
Sod Sulf-Potass Sulf-Mag Sulf95$5,909$62
See all 15 drugs
Every Part D drug this clinician prescribed
Linzess56$53,956$963
Creon11$28,533$2,594
Motegrity27$27,299$1,011
Dexlansoprazole Dr36$11,773$327
Sod Sulf-Potass Sulf-Mag Sulf95$5,909$62
Cholestyramine30$3,129$104
Pantoprazole109$1,839$17
Famotidine106$1,796$17
Esomeprazole Magnesium18$1,512$84
Lansoprazole12$1,140$95
Omeprazole42$619$15
Amitriptyline22$215$10
Ondansetron Odt15$112$7
Baclofen17$76$4
Ondansetron16$40$2

Year by year

Part D prescribing by year
20247602280% (0)24%$426,164
20236071870% (0)None$735,394
2022596190None35%$224,441
2021578212None47%$185,786
20205031420% (0)None$157,631
20194041510% (0)35%$90,721
2018643203None37%$200,123
20176762200% (0)None$201,697
2016722253NoneNone$164,035
2015608233None41%$437,125
2014570196NoneNone$201,870
20133621460% (0)None$62,700

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 13 drugs

Part D drugs prescribed in 2023
Stelara20$563,504$28,175
Linzess54$41,430$767
Motegrity25$22,535$901
Dexlansoprazole Dr24$10,665$444
Sutab23$3,839$167
Sod Sulf-Potass Sulf-Mag Sulf39$3,158$81
Lubiprostone12$1,574$131
Pantoprazole94$1,486$16
Suprep11$1,320$120
Famotidine55$1,317$24
Omeprazole68$764$11
Amitriptyline21$355$17
Hydrocortisone14$280$20

2022: 14 drugs

Part D drugs prescribed in 2022
Creon12$32,690$2,724
Linzess36$30,459$846
Motegrity27$14,035$520
Clenpiq41$7,280$178
Dexlansoprazole Dr13$7,258$558
Suprep31$3,596$116
Cholestyramine24$2,754$115
Sucralfate18$1,698$94
Pantoprazole67$1,408$21
Famotidine68$1,353$20
Omeprazole68$626$9
Amitriptyline24$253$11
Ondansetron12$189$16
Dicyclomine13$120$9

2021: 12 drugs

Part D drugs prescribed in 2021
Linzess66$50,959$772
Xifaxan13$26,627$2,048
Motegrity32$18,176$568
Dexilant23$12,429$540
Mesalamine11$9,694$881
Suprep79$8,746$111
Clenpiq41$6,573$160
Cholestyramine33$4,828$146
Pantoprazole50$1,050$21
Famotidine35$1,032$29
Omeprazole38$289$8
Amitriptyline29$288$10

2020: 10 drugs

Part D drugs prescribed in 2020
Motegrity39$22,875$587
Linzess36$22,023$612
Dexilant24$11,091$462
Suprep61$6,341$104
Cholestyramine36$4,122$115
Famotidine57$1,001$18
Pantoprazole37$848$23
Omeprazole31$450$15
Amitriptyline31$372$12
Rabeprazole11$310$28

2019: 11 drugs

Part D drugs prescribed in 2019
Creon11$30,696$2,791
Mesalamine12$16,440$1,370
Suprep67$6,673$100
Dexilant17$4,756$280
Cholestyramine19$2,719$143
Omeprazole37$693$19
Esomeprazole Magnesium11$551$50
Pantoprazole25$414$17
Amitriptyline26$301$12
Ranitidine31$264$9
Famotidine14$180$13

2018: 12 drugs

Part D drugs prescribed in 2018
Xifaxan24$66,379$2,766
Linzess41$20,391$497
Dexilant29$13,624$470
Amitiza22$8,111$369
Entecavir18$4,478$249
Pantoprazole89$1,312$15
Suprep11$1,046$95
Ranitidine84$1,001$12
Peg 3350-Electrolyte61$976$16
Gavilyte-N26$421$16
Omeprazole21$374$18
Dicyclomine13$146$11

2017: 16 drugs

Part D drugs prescribed in 2017
Humira11$49,467$4,497
Xifaxan16$28,441$1,778
Budesonide Ec19$20,176$1,062
Entecavir13$16,923$1,302
Linzess38$16,433$432
Dexilant61$16,202$266
Apriso23$8,773$381
Cholestyramine20$2,201$110
Esomeprazole Magnesium11$1,818$165
Peg 3350-Electrolyte78$1,151$15
Omeprazole52$1,056$20
Pantoprazole52$839$16
Ranitidine62$561$9
Gavilyte-N22$373$17
Dicyclomine13$105$8
Spironolactone13$90$7

2016: 17 drugs

Part D drugs prescribed in 2016
Humira13$51,458$3,958
Linzess44$16,145$367
Budesonide Ec18$8,124$451
Apriso23$6,374$277
Dexilant24$5,731$239
Delzicol12$3,534$294
Cholestyramine16$1,964$123
Peg 3350-Electrolyte89$1,358$15
Pantoprazole48$941$20
Rabeprazole12$940$78
Omeprazole61$814$13
Gavilyte-N45$803$18
Azathioprine16$484$30
Ranitidine43$370$9
Peg 3350-Electrolyte11$103$9
Prednisone17$62$4
Lorazepam15$59$4

2015: 15 drugs

Part D drugs prescribed in 2015
Entecavir15$18,635$1,242
Budesonide Ec11$8,626$784
Linzess21$6,216$296
Dexilant23$6,200$270
Cholestyramine11$1,808$164
Peg 3350-Electrolyte82$1,441$18
Pantoprazole69$1,084$16
Moviprep13$1,049$81
Sulfasalazine14$925$66
Gavilyte-N45$887$20
Omeprazole56$686$12
Azathioprine15$511$34
Ondansetron15$276$18
Ranitidine28$212$8
Lorazepam16$68$4

2014: 17 drugs

Part D drugs prescribed in 2014
Baraclude14$22,748$1,625
Budesonide Ec14$11,716$837
Nexium19$6,379$336
Dexilant28$6,344$227
Linzess13$4,127$317
Cholestyramine13$1,430$110
Rabeprazole11$1,203$109
Peg-335061$1,096$18
Pantoprazole46$977$21
Sulfasalazine11$883$80
Omeprazole38$773$20
Sulfazine11$608$55
Azathioprine13$465$36
Gavilyte-N25$435$17
Ranitidine35$387$11
Ondansetron15$287$19
Trilyte With Flavor Packets12$231$19

2013: 11 drugs

Part D drugs prescribed in 2013
Baraclude16$23,878$1,492
Nexium20$6,353$318
Omeprazole48$1,659$35
Moviprep15$1,058$71
Peg-3350 With Flavor Packs42$778$19
Sulfasalazine13$673$52
Azathioprine17$645$38
Pantoprazole21$443$21
Gavilyte-N21$392$19
Ranitidine23$252$11
Baclofen11$91$8

Money from drug and device companies

$66 in 2025

Industry payments by year
202522None$66
202311None$14
202111None$14

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Braintree LaboratoriesSuflave$35
1 payment
  • Meals for Suflave · 2025-08-28 · $35
PfizerVelsipity$31
1 payment
  • Education for Velsipity · 2025-04-14 · $31
See all 2 published payments
Every published payment
Braintree LaboratoriesMeals · 2025-08-28Suflave$35
PfizerEducation · 2025-04-14Velsipity$31
See earlier years (2023, 2021)

2023: $14

Payments by company in 2023
AbbvieLinzess$14
1 payment
  • Meals for Linzess · 2023-11-22 · $14

2021: $14

Payments by company in 2021
CelgeneZeposia$14
1 payment
  • Meals for Zeposia · 2021-07-22 · $14

Professional record

NPI
1376657734
Licence
CA A69657California A69657: Current · expires 2026-11-30
Trained
University of Southern California Keck School of Medicine, 1998
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RG0100X (207RG0100X)
Mailing address
321 Middlefield Rd Ste 260, Menlo Park, CA, 94025
NPI first listed
2006-08-19
NPI last updated
2024-04-15
NPI record certified
2024-04-15

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 795 El Camino Real, Palo Alto, CA, 94301